# Andrew Kozlov

> Andrew Kozlov is a Series A investor at 4BIO Capital (London) backing Biotechnology and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [4BIO Capital](https://shizune.co/investors/profile/4bio-capital-partners)
- Location: London, United Kingdom
- Total investments: 2
- Last investment: Mar 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/andrew-kozlov-6109862/
- Website: http://www.4biocapital.com

Andrew Kozlov is a Series A investor at 4BIO Capital in London focused on Biotechnology and Medical. Andrew Kozlov - Managing Partner @ 4BIO Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Consulting | 1 | 50% |
| Therapeutics | 1 | 50% |
| Manufacturing | 1 | 50% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ascend Gene & Cell Therapies | Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form. | $65.9M | Series A | Mar 20, 2023 |  |
| IAG, Image Analysis Group | IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure. This includes bringing AI, Machine Learning and smart image analysis methods to ensure the speed and cost-effectiveness, while delivering true insights about your mechanism of action and patients’ response, inreal-time. | $5.2M |  | Apr 30, 2015 |  |

2 of 2 investments shown.

## Co-investors
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 2 deals together
- [DCVC Bio](https://shizune.co/investors/profile/dcvc-bio) — VC Fund, 2 deals together
- [Ajinomoto](https://shizune.co/investors/profile/ajinomoto) — VC Fund, 1 deal together
- [Cathay Health](https://shizune.co/investors/profile/cathay-health) — VC Fund, 1 deal together
- [Deerfield Capital Management](https://shizune.co/investors/profile/deerfield-management) — VC Fund, 1 deal together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 1 deal together

## About 4BIO Capital

VC Fund · London, United Kingdom

4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech -biologics, gene and cell therapy and bioinformatics.

5 contacts available at 4BIO Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Kozlov | Managing Partner | https://shizune.co/investors/profile/andrey-kozlov |
| Dmitry Kuzmin | Managing Partner | https://shizune.co/investors/profile/dmitry-kuzmin |
| Kieran Mudryy | Partner | https://shizune.co/investors/profile/kieran-mudryy |
| Owen Smith | Principal | https://shizune.co/investors/profile/owen-smith-b474 |
| Vasily Fedorin | Principal | https://shizune.co/investors/profile/vasily-fedorin |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Andrew Kozlov invest in?

Andrew Kozlov invests primarily in Biotechnology, Medical and Consulting startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Andrew Kozlov last invest?

The most recent investment recorded for Andrew Kozlov closed in Mar 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co